MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with H

Hydrochlorothiazide

Hydrochlorothiazide 12.5mg tablets

No stability information

Stability notes for Hydrochlorothiazide 12.5mg tablets

There are no stability notes for this medicine.

Supplier

Hydrochlorothiazide 12.5mg tablets (Special Order)

Hydrochlorothiazide 25mg tablets

No stability information

Stability notes for Hydrochlorothiazide 25mg tablets

There are no stability notes for this medicine.

Supplier

Hydrochlorothiazide 25mg tablets (Part VIIID Drug Tariff Special Order)

Hydrochlorothiazide 50mg tablets

No stability information

Stability notes for Hydrochlorothiazide 50mg tablets

There are no stability notes for this medicine.

Supplier

Hydrochlorothiazide 50mg tablets (Special Order)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.